J. Kieler
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- Cancer Research and Treatments
Papers in
-
- Cancer Research and Treatments 9
- Immunology 18
- Immunotherapy and Immune Responses 15
- Immune Cell Function and Interaction 6
- Co-authors
- J BubeníkBrian ChristensenJohn L. MooreT JandlováNikolai N. VoitenokVladimir PrassolovPeter M. ChumakovM. Vilien
In The Last Decade
J. Kieler
55 papers receiving 440 citations
Peers
Comparison fields: 5 of 73
- Immunology 167
- Biotechnology 45
- Oncology 134
- Cancer Research 67
- Biochemistry 26
Countries citing papers authored by J. Kieler
This map shows the geographic impact of J. Kieler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kieler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kieler more than expected).
Fields of papers citing papers by J. Kieler
This network shows the impact of papers produced by J. Kieler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kieler. The network helps show where J. Kieler may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Kieler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 5 | |
| 2 | 1995 | 6 | |
| 3 | 1993 | 6 | |
| 4 | 1993 | 4 | |
| 5 | 1990 | 7 | |
| 6 | 1990 | 8 | |
| 7 | 1989 | 12 | |
| 8 | 1988 | 68 | |
| 9 | 1988 | 20 | |
| 10 | 1988 | 5 | |
| 11 | 1987 | 7 | |
| 12 | Local treatment with human recombinant interleukin 2 inhibits growth of MC-induced sarcomas in syngeneic mice. | 1986 | 8 |
| 13 | A classification of human urothelial cells propagated in vitro. | 1985 | 47 |
| 14 | 1984 | 10 | |
| 15 | [Treatment of brain tumors with anticancer pellet--experimental and clinical study (author's transl)]. | 1982 | 18 |
| 16 | 1969 | 8 | |
| 17 | Studies on the antineoplastic effect of vanadium salts. | 1965 | 14 |
| 18 | The use of tissue cultivation in cancer research. | 1961 | 2 |
| 19 | Studies on oxidative metabolism of the Yoshida ascites tumour cells. | 1960 | 5 |
| 20 | 1952 | 17 |
About J. Kieler
J. Kieler is a scholar working on Biotechnology, Immunology, Biochemistry, Oncology and Cancer Research, having authored 56 papers that have together received 500 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Cancer Research and Treatments (9 papers), Bladder and Urothelial Cancer Treatments (9 papers), Virus-based gene therapy research (6 papers), Immune Cell Function and Interaction (6 papers), Tissue Engineering and Regenerative Medicine (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). The work is most often cited by research in Immunology (167 citations), Biotechnology (45 citations), Oncology (134 citations), Cancer Research (67 citations) and Biochemistry (26 citations). J. Kieler has collaborated with scholars based in Denmark, Poland and Czechia. Frequent co-authors include J Bubeník, Brian Christensen, John L. Moore, T Jandlová, Nikolai N. Voitenok, Vladimir Prassolov, Peter M. Chumakov, M. Vilien, Wang Cy and Per Briand. Their work appears in journals such as Experimental Biology and Medicine, Immunology Letters, Histochemistry and Cell Biology, Cancer Immunology Immunotherapy and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.